Tucker Carlson criticizes Facebook for censoring interview with Chinese virologist
(Natural News) Facebook and other tech giants have engaged in a troubling pattern of censoring speech surrounding major issues in the coronavirus debate, Fox News host Tucker Carlson argued during his Wednesday night monologue. (Article by Dam Dorman republished from FoxNews.com) Carlson’s comments came after Facebook slapped a warning label on video of his Tuesday interview with Chinese virologist Dr. Li-Meng Yan,... (Source: NaturalNews.com)
Source: NaturalNews.com - September 18, 2020 Category: Consumer Health News Source Type: news

A Virologist Explains The Realities Of Biomedical Research During A Pandemic
Dr. Jason Kindrachuk, an infectious disease expert, examines the progress so far and the challenges that remain for researchers studying Covid-19 vaccines and treatments. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2020 Category: Pharmaceuticals Authors: Jason Kindrachuk, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick Coronavirus Source Type: news

Stabilizing the prefusion SARS-CoV-2 spike
(Source: ScienceNOW)
Source: ScienceNOW - September 17, 2020 Category: Science Authors: Vinson, V. Tags: Biochemistry, Virology twis Source Type: news

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is metastable and difficult to produce recombinantly. We characterized 100 structure-guided spike designs and identified 26 individual substitutions that increased protein yields and stability. Testing combinations of beneficial substitutions resulted in the identification of HexaPro, a variant with six beneficial proline substitutions exhibiting higher expression than its parental construct (by a factor of 10) as well as the ability to withstand...
Source: ScienceNOW - September 17, 2020 Category: Science Authors: Hsieh, C.-L., Goldsmith, J. A., Schaub, J. M., DiVenere, A. M., Kuo, H.-C., Javanmardi, K., Le, K. C., Wrapp, D., Lee, A. G., Liu, Y., Chou, C.-W., Byrne, P. O., Hjorth, C. K., Johnson, N. V., Ludes-Meyers, J., Nguyen, A. W., Park, J., Wang, N., Amengor, Tags: Biochemistry, Virology reports Source Type: news

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in an unprecedented public health crisis. There are no approved vaccines or therapeutics for treating COVID-19. Here we report a humanized monoclonal antibody, H014, that efficiently neutralizes SARS-CoV-2 and SARS-CoV pseudoviruses as well as authentic SARS-CoV-2 at nanomolar concentrations by engaging the spike (S) receptor binding domain (RBD). H014 administration reduced SARS-CoV-2 titers in infected lungs and prevented pulmonary pathology in a human angiotensin-converting enzyme 2 mouse ...
Source: ScienceNOW - September 17, 2020 Category: Science Authors: Lv, Z., Deng, Y.-Q., Ye, Q., Cao, L., Sun, C.-Y., Fan, C., Huang, W., Sun, S., Sun, Y., Zhu, L., Chen, Q., Wang, N., Nie, J., Cui, Z., Zhu, D., Shaw, N., Li, X.-F., Li, Q., Xie, L., Wang, Y., Rao, Z., Qin, C.-F., Wang, X. Tags: Biochemistry, Microbiology reports Source Type: news

COVID-19: background information, PHE (updated 16th September 2020)
Information on COVID-19 including epidemiology, virology and clinical features. Update in this version (published 16th September) - updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 16, 2020 Category: Consumer Health News Source Type: news

Without Good Public Health Strategy, The Coronavirus Pandemic Could Make Antimicrobial Resistance Worse
Dr. Rodney Rohde, a virologist and clinical laboratory expert, explains how the Covid-19 pandemic can make antimicrobial resistance a bigger problem if health systems aren ’t careful. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 16, 2020 Category: Pharmaceuticals Authors: Rodney Rohde, Contributor Tags: Healthcare /healthcare Innovation /innovation Editors' Pick editors-pick Coronavirus Source Type: news

Scientists to examine the possibility Covid-19 leaked from a Chinese lab
An international team led by Dr Peter Daszak, a British zoologist, will delve into all theories of the virus's origins including that it leaked from a lab in China (pictured, Wuhan Institute of Virology). (Source: the Mail online | Health)
Source: the Mail online | Health - September 16, 2020 Category: Consumer Health News Source Type: news

Chinese virologist claims the coronavirus was cooked up in a military medical facility
Li-Meng Yan, who claims to be a former researcher from Hong Kong, says the virus was built by manipulating the genetic material of two bat coronaviruses. (Source: the Mail online | Health)
Source: the Mail online | Health - September 16, 2020 Category: Consumer Health News Source Type: news

COVID-19: background information, PHE (updated 14th September 2020)
Information on COVID-19 including epidemiology, virology and clinical features. 14 September 2020 Updated global case numbers. 11 September 2020 Updated global case numbers. 9 September 2020 Updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 15, 2020 Category: Consumer Health News Source Type: news

Chinese virologist claims to have "smoking gun" evidence that COVID-19 is lab-created
(Natural News) Dr. Li-Meng Yan, M.D., Ph.D., a virologist from China who recently fled the communist country as well as her prestigious job at Hong Kong University (HKU), is back in the news with claims that the Wuhan coronavirus (COVID-19) was created by Chinese scientists in a laboratory. Appearing on British television, Dr. Li-Meng talked... (Source: NaturalNews.com)
Source: NaturalNews.com - September 15, 2020 Category: Consumer Health News Source Type: news

COVID-19: background information, PHE (updated 11th September 2020)
Information on COVID-19 including epidemiology, virology and clinical features. Update in this version (published 11th September 2020) - updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 11, 2020 Category: Consumer Health News Source Type: news

COVID-19: background information, PHE (updated 9th September 2020)
Information on COVID-19 including epidemiology, virology and clinical features. Update in this version (published 9th September 2020) - updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 10, 2020 Category: Consumer Health News Source Type: news

COVID-19: background information, PHE (updated 7th September 2020)
Information on COVID-19 including epidemiology, virology and clinical features. Update in this version (published 4th September 2020) - updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 7, 2020 Category: Consumer Health News Source Type: news

House parties could be banned until 2023 because coronavirus 'is not disappearing', scientist warns 
German virologist Professor Hendrik Streeck says that parties and other large gatherings will need to stop completely for the next three years in order to lower infections to a manageable level. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2020 Category: Consumer Health News Source Type: news

COVID-19: epidemiology, virology and clinical features, PHE (updated 2nd September 2020)
Latest updates to this information 2 September 2020: updated with latest global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 3, 2020 Category: Consumer Health News Source Type: news

COVID-19: background information, PHE (updated 2nd September 2020)
Information on COVID-19 including epidemiology, virology and clinical features. Update in this version (published 2nd September 2020) - updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 2, 2020 Category: Consumer Health News Source Type: news

Coronavirus Is Surging In the U.S. Midwest. Here ’s What’s Going on Across the Region
The epicenter of the U.S. coronavirus epidemic is a moving target. In the spring, it was New York City. Then Florida, Texas and California became hotspots. And now, with fall approaching, the outbreak has a new locus: the Midwest. Daily coronavirus cases and deaths are trending downward nationally after a spike this summer. There were about 34,000 new cases of coronavirus and about 600 deaths on Aug. 31—decreases of about 12% and 30%, respectively, compared to two weeks ago. But the Midwest is an exception to the trend. It is the country’s only region where daily case counts are rising in nearly every state&mda...
Source: TIME: Health - September 1, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

How Long Are COVID-19 Antibodies Protective? How Long Are COVID-19 Antibodies Protective?
WebMD Chief Medical Officer John Whyte talks with virologist Dr Alexander Greninger about whether coronavirus antibodies can protect people from COVID-19 infection -- or reinfection -- and for how long.WebMD (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2020 Category: Consumer Health News Tags: Public Health & Prevention Expert Interview Source Type: news

COVID-19: background information, PHE (updated 28th August 2020)
Information on COVID-19 including epidemiology, virology and clinical features. Update in this version (published 28th August 2020) - updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 28, 2020 Category: Consumer Health News Source Type: news

For $5 and in 15 Minutes You Can Learn If You Have COVID-19
On Aug. 26, the U.S. Food and Drug Administration (FDA) gave an emergency use authorization (EUA) for a rapid COVID-19 test that can produce results in just 15 minutes, which could not only increase the number of people tested in the U.S., but also identify those who are positive sooner, so they can self-isolate and limit spread of the disease. The testing device, made by Abbott Laboratories and called BinaxNOW Ag Card, is about the size of a credit card and can be easily used anywhere people need to be tested. It analyzes samples from a nasal swab and comes with an app that people can download to receive their results&mda...
Source: TIME: Health - August 27, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

COVID-19: background information, PHE (updated 26th August 2020)
Information on COVID-19 including epidemiology, virology and clinical features. Update in this version (published 26th August 2020) - updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 27, 2020 Category: Consumer Health News Source Type: news

Coronavirus reinfection – what it actually means, and why you shouldn’t panic | Zania Stamataki for The Conversation
Naturally, people are worried about what the first confirmed case of reinfection means for the pandemicScientists in Hong Kong have reported thefirst confirmed case of reinfectionwith the coronavirus that causes Covid-19, reportedly backed up by genetic sequences of the two episodes of the 33-year-old man ’s infections in March and in August 2020. Naturally, people are worried what this could mean for our chances of resolving the pandemic. Here’s why they shouldn’t worry.Nearly nine months after the first infection with the novel coronavirus, we have very poor evidence for reinfection. However, virologist...
Source: Guardian Unlimited Science - August 27, 2020 Category: Science Authors: Zania Stamataki for the Conversation Tags: Coronavirus outbreak Health Hong Kong Infectious diseases Science Source Type: news

New models help predict liver cancer after successful hepatitis C virus (HCV) treatment
(Spink Health) Digital ILC 2020: European scientists develop new predictive models for HCC in patients with chronic HCV after a sustained virological response to direct-acting antiviral therapy (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 26, 2020 Category: Cancer & Oncology Source Type: news

Africa: Polio Eradication - a "Battle I Fought with Undiluted Passion" - Professor Oyewale Tomori
[WHO] At 74, Professor Oyewale Tomori is the leading virologist who helped spearhead Nigeria's efforts to kick polio out of the country, a feat that was accomplished in June 2020 after decades of efforts. (Source: AllAfrica News: Polio)
Source: AllAfrica News: Polio - August 25, 2020 Category: Infectious Diseases Source Type: news

Exclusive: The Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Science - August 25, 2020 Category: Science Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

Exclusive: The Chinese Scientist Who Sequenced the First COVID-19 Genome Speaks Out About the Controversies Surrounding His Work
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - August 25, 2020 Category: Consumer Health News Authors: Charlie Campbell / Shanghai Tags: Uncategorized COVID-19 overnight Source Type: news

A New Study Suggests COVID-19 Reinfection Is Possible. Here ’s What to Know
Preliminary research released Monday suggests it’s possible to get COVID-19 twice—but experts say the news is not as concerning as that headline may seem. The new research, which was accepted for publication in the journal Clinical Infectious Diseases, details the case of a 33-year-old man living in Hong Kong. He first tested positive for COVID-19 in late March and developed symptoms including cough, sore throat, fever and headache. He made a full recovery, but again tested positive for COVID-19 while traveling home from Europe in mid-August. This time, he did not have any symptoms. The Hong Kong-based research...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

COVID-19: background information, PHE (updated 24th August 2020)
Information on COVID-19 including epidemiology, virology and clinical features. Update in this version (published 24th August 2020) - updated global case numbers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 24, 2020 Category: Consumer Health News Source Type: news

Angola: Covid-19 - Benguela's Molecular Laboratory Kicks Off Testing
[ANGOP] Benguela -- The regional molecular virology laboratory, located in Benguela General Hospital, started on Thursday, to perform the first tests for diagnosis of Sars cov2, as part of the fight against the Covid-19 pandemic. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 21, 2020 Category: African Health Source Type: news

Angola: Covid-19 - Huila's Laboratory Begins Testing
[ANGOP] Lubango -- Huila's virology laboratory, set up at Lubango Central Hospital, began on Thursday, diagnosing the COVID-19 pandemic, with six daily tests, following an experiment carried out on Wednesday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 21, 2020 Category: African Health Source Type: news

How UCLA scientists are using stem cells to take on COVID-19
As the COVID-19 pandemic rages on, UCLA researchers are rising to the occasion by channeling their specialized expertise to seek new and creative ways to reduce the spread of the virus and save lives. Using years ’ — or even decades’ — worth of knowledge they’ve acquired studying other diseases and biological processes, many of them have shifted their focus to the novel coronavirus, and they’re collaborating across disciplines as they work toward new diagnostic tests, treatments and vaccines.At UCLA, more than 230 research projects, including several being led by members of theEli and Ed...
Source: UCLA Newsroom: Health Sciences - August 20, 2020 Category: Universities & Medical Training Source Type: news

Vaccine developed for human herpesvirus 6B (HHV-6B)
(Kobe University) A research group led by Professor MORI Yasuko (of the Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine) has revealed that the HHV-6B glycoprotein complex gH/gL/gQ1/gQ2 is an effective vaccine candidate for human herpesvirus 6B (HHV-6B). There are still no methods to treat nor prevent HHV-6B infection, and this study represents the first attempt in the world at developing a vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 20, 2020 Category: Infectious Diseases Source Type: news

An antibody cocktail against SARS-CoV-2
(Source: ScienceNOW)
Source: ScienceNOW - August 20, 2020 Category: Science Authors: Vinson, V. Tags: Virology twis Source Type: news

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Antibodies targeting the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present a promising approach to combat the coronavirus disease 2019 (COVID-19) pandemic; however, concerns remain that mutations can yield antibody resistance. We investigated the development of resistance against four antibodies to the spike protein that potently neutralize SARS-CoV-2, individually as well as when combined into cocktails. These antibodies remain effective against spike variants that have arisen in the human population. However, novel spike mutants rapidly appeared after in vitro passaging in the presence...
Source: ScienceNOW - August 20, 2020 Category: Science Authors: Baum, A., Fulton, B. O., Wloga, E., Copin, R., Pascal, K. E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G. S., Murphy, A. J., Stahl, N., Yancopoulos, G. D., Kyratsous, C. A. Tags: Virology reports Source Type: news

Nigeria: IHVN, ISN Commence Research On NCDs Among People Living With HIV/Aids
[This Day] The Institute of Human Virology Nigeria (IHVN) and the ISN Medical have commenced research to ascertain the burden, prevalence and incidence of Non-Communicable Diseases (NCD) among people living with HIV in Nigeria. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - August 14, 2020 Category: Infectious Diseases Source Type: news

'They've jumped the gun': scientists worry about Russia's Covid-19 vaccine
Rising chorus of concern over Sputnik V vaccine stems from opaque development and lack of mass testingCoronavirus – latest updatesSee all our coronavirus coverageIn 1977, Scott Halstead, a virologist at the University of Hawaii, was studying dengue fever when he noticed a now well-known but then unexpected feature of the disease.Animals that had already been exposed to one of the four closely related viruses that cause dengue and produced antibodies to it, far from being protected against other versions, became sicker when infected a second time, and it was the antibodies produced by the first infection that were res...
Source: Guardian Unlimited Science - August 13, 2020 Category: Science Authors: Peter Beaumont Tags: Medical research Coronavirus outbreak Science World news Russia Europe Source Type: news

ViiV Healthcare Announces FDA Approval of an Expanded Indication for Dovato (dolutegravir/lamivudine), a Complete Two-Drug Regimen for Virologically Suppressed Adults with HIV-1
London, 6 August 2020 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Dovato... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 6, 2020 Category: Drugs & Pharmacology Source Type: news

SVR From DAA, Interferon-based Treatments for HCV and HCC Risk SVR From DAA, Interferon-based Treatments for HCV and HCC Risk
How does sustained virologic response from direct-acting antiviral and interferon-based treatments impact the risk of developing hepatocellular carcinoma?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - August 5, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patients
Basel, 5 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has authorised the cobas ® EBV test. This is the first quantitative in vitro diagnostic test for Epstein-Barr virus (EBV) DNA in the United States. This authorisation gives healthcare professionals a key tool in monitoring transplant patients at risk for complications from infections or reactivations of EBV, by providing t he ability to run a large number of patient tests for this virus in a short period of time.“Monitoring of Epstein-Barr virus DNA can help prevent progression of life-threat...
Source: Roche Media News - August 5, 2020 Category: Pharmaceuticals Source Type: news

Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patients
Basel, 5 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has authorised the cobas ® EBV test. This is the first quantitative in vitro diagnostic test for Epstein-Barr virus (EBV) DNA in the United States. This authorisation gives healthcare professionals a key tool in monitoring transplant patients at risk for complications from infections or reactivations of EBV, by providing t he ability to run a large number of patient tests for this virus in a short period of time.“Monitoring of Epstein-Barr virus DNA can help prevent progression of life-threat...
Source: Roche Investor Update - August 5, 2020 Category: Pharmaceuticals Source Type: news

Chinese scientist who fled to U.S. says coronavirus was "created in military lab"
(Natural News) A former virology specialist from The University of Hong Kong’s School of Public Health has come forward to claim that the Wuhan coronavirus (COVID-19) was “created in a military lab,” and was possibly designed to be a bioweapon. Dr. Li-Meng Yan says that during her time at the school – Dr. Li-Meng has... (Source: NaturalNews.com)
Source: NaturalNews.com - August 4, 2020 Category: Consumer Health News Source Type: news

Covid-19 survivors should be exempt from having to self-isolate, government scientific advisers say 
The Scientific Advisory Group for Emergencies (Sage) studied evidence from virologists that found it's likely that coronavirus survivors cannot be infected again in the short term. (Source: the Mail online | Health)
Source: the Mail online | Health - August 4, 2020 Category: Consumer Health News Source Type: news

Transferrin identified as potential contributor to COVID-19 severity
(University of Kent) The University of Kent's School of Biosciences and the Institute of Medical Virology at Goethe-University, Frankfurt am Main, have identified that a glycoprotein known as transferrin may critically contribute to severe forms of COVID-19. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 3, 2020 Category: Biology Source Type: news

New published study from K-State virologists identifies potential COVID-19 treatment
(Kansas State University) Yunjeong Kim and Kyeong-Ok 'KC' Chang, virologists in the College of Veterinary Medicine at Kansas State University, have published a study showing a possible therapeutic treatment for COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 3, 2020 Category: Infectious Diseases Source Type: news

Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies
NEW BRUNSWICK, N.J., July 30, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that its lead vaccine candidate protected against infection with SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies. The data, published in Nature, show the Company’s investigational adenovirus serotype 26 (Ad26) vector-based vaccine elicited a robust immune response as demonstrated by “neutralizing antibodies,” successfully preventing subsequent infection and providing complete or near-complete protection in the lungs from the virus in non-human primates (NHPs) in the pre-clinical s...
Source: Johnson and Johnson - July 30, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news

Wuhan coronavirus hunter Shi Zhengli speaks out
(Source: ScienceNOW)
Source: ScienceNOW - July 30, 2020 Category: Science Authors: Cohen, J. Tags: Asia/Pacific News, Epidemiology, Immunology, Virology In Depth Source Type: news

Global plan seeks to promote vaccine equity, spread risks
(Source: ScienceNOW)
Source: ScienceNOW - July 30, 2020 Category: Science Authors: Kupferschmidt, K. Tags: Epidemiology, Immunology, Medicine, Diseases, Scientific Community, Virology In Depth Source Type: news

Epidemic in Northern California
(Source: ScienceNOW)
Source: ScienceNOW - July 30, 2020 Category: Science Authors: Ash, C. Tags: Epidemiology, Virology twis Source Type: news